Each individual topic surrounding the system design has its own associated flowchart that identifies activities and go/no go decision points.
Thus, the phase II randomised design leads to a double go not go decision.
Therefore, CYP2D6 substrate status is a No Go decision point in CNS drug development and is one of the FDA recommended CYPs for screening.
And Novartis is encouraging more, and faster, go no go decisions.
You also throw in a good, healthy dose of informatics and bioinformatics, which companies use to make go no go decisions on projects.
At this stage, predicting which of the novel candidates might also prove immunogenic in human infants will be largely empirical and lead to difficult "go-no go" decisions.
Meta-models can describe PD or disease progression, and are now frequently used to underwrite go/no go decisions during drug development.
Exposing design decisions goes beyond decisions about the PD and teachers.
Latest Go/No-go decision - before 07 35.
An example of a go no-go decision development program is presented.
In both instances, the time to milestone go/no-go decision is adjusted accordingly.
